Amgen
AMGN
3,130 hedge funds and large institutions have $154B invested in Amgen in 2026 Q1 according to their latest regulatory filings, with 222 funds opening new positions, 1,206 increasing their positions, 1,246 reducing their positions, and 124 closing their positions.
79% more first-time investments, than exits
New positions opened: 222 | Existing positions closed: 124
29% more funds holding in top 10
Funds holding in top 10: 51 → 66 (+15)
28% more call options, than puts
Call options by funds: $1.89B | Put options by funds: $1.47B
5% more capital invested
Capital invested by funds: $147B → $154B (+$7.55B)
1% more funds holding
Funds holding: 3,085 → 3,130 (+45)
3% less repeat investments, than reductions
Existing positions increased: 1,206 | Existing positions reduced: 1,246
1.88% less ownership
Funds ownership: 83.42% → 81.55% (-1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$2.21B |
| 2 |
JP Morgan Chase
New York
|
+$1.78B |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$823M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$402M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$343M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$3.94B |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$433M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$432M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$357M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$341M |
AMGN Hedge Fund Activity: Q1 2026 in Review
3,130 of the 8,133 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2026, worth a combined $154B — up 5.1% from $147B a quarter earlier.
Buyers outnumbered sellers: 222 funds opened new AMGN positions and 124 closed out — a net gain of 98 holders — while 1,206 added to existing stakes and 1,246 trimmed.
The largest buyer was Capital World Investors, adding an estimated $2.21B. The largest seller was Capital International Investors, cutting an estimated $3.94B.
- 3,130 institutional investors held Amgen (AMGN) as of Q1 2026, up from 3,085 in Q4 2025.
- Funds reported $154B of Amgen stock for Q1 2026, up 5.1% quarter-over-quarter.
- 222 funds opened new Amgen positions in Q1 2026 and 124 closed out, a net change of +98 holders.
- The largest Amgen buyer in Q1 2026 was Capital World Investors, an estimated $2.21B added.
- The largest Amgen seller in Q1 2026 was Capital International Investors, an estimated $3.94B sold.
Based on aggregated 13F filings for Q1 2026.